Fig. 12
From: Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells
Flow cytometric analysis of MMP in human CRC cell lines treated with Sora, Que or Kmf and a combination of both. A The SW1116 human CRC cell line was UT, or treated with Sora (5 µM), Que (200 and 400 µM) and simultaneous combinations of Sora (5 µM) and Que (200 or 400 µM) for 72 h. B The SW837 human CRC cell line was UT, or treated with Sora (5 µM), Kmf (200 µM), Kmf (400 µM), and sequential treatments of Sora (5 µM) and Kmf (200 or 400 µM) for 72 h. MMP, mitochondrial membrane potential; Sora, sorafenib; Que, quercetin; Kmf, kaempferol; UT, untreated; CRC, colorectal cancer